The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2026
Filed:
Jan. 14, 2022
Applicant:
Galderma Holding SA, Zug, CH;
Inventors:
Peter Morgan, Uppsala, SE;
Lubica Macakova, Stockholm, SE;
Assignee:
Galderma Holding SA, Zug, CH;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/18 (2006.01); A61C 8/00 (2006.01); A61F 2/00 (2006.01); A61K 8/02 (2006.01); A61K 8/04 (2006.01); A61K 8/20 (2006.01); A61K 8/49 (2006.01); A61K 8/73 (2006.01); A61K 8/81 (2006.01); A61K 8/85 (2006.01); A61K 8/86 (2006.01); A61L 2/04 (2006.01); A61L 2/08 (2026.01); A61L 27/02 (2006.01); A61L 27/20 (2006.01); A61L 27/52 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01); C08L 1/28 (2006.01); C08L 67/04 (2006.01); C08L 71/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/18 (2013.01); A61K 8/025 (2013.01); A61K 8/042 (2013.01); A61K 8/20 (2013.01); A61K 8/731 (2013.01); A61K 8/85 (2013.01); A61K 8/86 (2013.01); A61L 2/04 (2013.01); A61L 2/08 (2013.01); A61L 27/025 (2013.01); A61L 27/20 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61Q 19/08 (2013.01); C08L 1/286 (2013.01); C08L 67/04 (2013.01); C08L 71/00 (2013.01); A61K 2800/412 (2013.01); A61K 2800/87 (2013.01); A61K 2800/91 (2013.01); A61L 2300/402 (2013.01); A61L 2400/06 (2013.01);
Abstract
Described are ready-to-use injectable compositions comprising polymeric microspheres or microparticles of non-animal origin, a hydrogel comprising water and a cellulose-derivative gelling agent, and polysorbate 80. Further described are methods of using the ready-to-use injectable compositions for reparative or plastic surgery, esthetic dermatology, facial contouring, body contouring, and gingival augmentation.